GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Newbury Pharmaceuticals NEWBRY.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

1.70

+5.59%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Newbury Pharmaceuticals annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2026FY2025FY2024FY2023FY2022
RevenueSEK 42.7m—SEK 36.8mSEK 10.3mSEK 5.5m
Operating income−SEK 20.7m−SEK 20.6m−SEK 14.1m−SEK 19.6m−SEK 14.7m
Net income−SEK 22.9m−SEK 20.6m−SEK 15.4m−SEK 19.4m−SEK 14.7m
Free cash flow−SEK 19.7m—−SEK 26.6m−SEK 24.1m−SEK 39.4m
Total assetsSEK 76.2m—SEK 90.9mSEK 72.9mSEK 86.9m
Shareholders' equitySEK 19.6m—SEK 51.9mSEK 49.4mSEK 68.8m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.